These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 38979724

  • 1. Intravenous Immunoglobulins Alone for the Desensitization of Lung Transplant Recipients with Preformed Donor Specific Antibodies and Negative Flow Cytometry Crossmatch.
    Abdulqawi R, Alawwami M, Aldosari O, Aldosari Z, Alhuqbani M, Saleh RA, Esendagli D, Aldakhil H, De Vol EB, Alkattan K, Marquez KAH, Saleh W, Sandoqa S, Al-Mutairy EA.
    Clin Transplant; 2024 Jul; 38(7):e15374. PubMed ID: 38979724
    [Abstract] [Full Text] [Related]

  • 2. Clinical Significance of Pretransplant Donor-Specific Antibodies in the Setting of Negative Cell-Based Flow Cytometry Crossmatching in Kidney Transplant Recipients.
    Adebiyi OO, Gralla J, Klem P, Freed B, Davis S, Wiseman AC, Cooper JE.
    Am J Transplant; 2016 Dec; 16(12):3458-3467. PubMed ID: 27140940
    [Abstract] [Full Text] [Related]

  • 3. Perioperative Desensitization Improves Outcomes Among Crossmatch Positive Recipients of Deceased Donor Renal Transplants.
    Sharma A, King A, Kumar D, Behnke M, McDougan F, Kimball PM.
    Prog Transplant; 2016 Jun; 26(2):157-61. PubMed ID: 27207404
    [Abstract] [Full Text] [Related]

  • 4. Impact of pretransplant donor-specific antibodies on kidney allograft recipients with negative flow cytometry cross-matches.
    Kwon H, Kim YH, Choi JY, Shin S, Jung JH, Park SK, Han DJ.
    Clin Transplant; 2018 Jun; 32(6):e13266. PubMed ID: 29676812
    [Abstract] [Full Text] [Related]

  • 5. Successful desensitization and kidney transplantation in the presence of donor-specific anti-human leukocyte antigen antibodies in kidney transplant recipients.
    Khan MT, Hamid RB, Sarfaraz S, Lal N, Ahmed J, Luxmi S.
    Saudi J Kidney Dis Transpl; 2020 Jun; 31(6):1432-1438. PubMed ID: 33565460
    [Abstract] [Full Text] [Related]

  • 6. Clinical significance of low pre-transplant donor specific antibodies (DSA) in living donor kidney recipients with negative complement-dependent cytotoxicity crossmatches (CDCXM), and negative flow cytometry crossmatches (FLXM) - A single-center experience.
    Olszowska-Zaremba N, Gozdowska J, Zagożdżon R.
    Transpl Immunol; 2022 Oct; 74():101672. PubMed ID: 35868613
    [Abstract] [Full Text] [Related]

  • 7. Impact of alloantibody strength in crossmatch negative DSA positive kidney transplantation.
    Wu P, Jin J, Everly MJ, Lin C, Terasaki PI, Chen J.
    Clin Biochem; 2013 Oct; 46(15):1389-93. PubMed ID: 23726814
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. One-Year Outcomes of Living Related Kidney Transplant in Patients With Preformed HLA Donor-Specific Antibodies: A Single-Center Experience in Malaysia.
    Jalalonmuhali M, Ng KP, Mohd Shariff NH, Lee YW, Wong AH, Gan CC, Lim SK.
    Transplant Proc; 2020 Oct; 52(6):1718-1722. PubMed ID: 32448671
    [Abstract] [Full Text] [Related]

  • 10. Pre-transplant crossmatch-negative donor-specific anti-HLA antibody predicts acute antibody-mediated rejection but not long-term outcomes in kidney transplantation: an analysis of the Korean Organ Transplantation Registry.
    Lee H, Lee H, Sun IO, Park JH, Park JW, Ban TH, Yang J, Kim MS, Yang CW, Chung BH, Korean Organ Transplantation Registry Study Group.
    Front Immunol; 2024 Oct; 15():1420351. PubMed ID: 39055708
    [Abstract] [Full Text] [Related]

  • 11. Highly Sensitized Patients: Miami Transplant Institute Experience.
    Mattiazzi AD, Centeno A, Amador A, Fernandez-Bango C, Scowby CD, O'Rourke M, Hill-Matthie T, Patel R, Barrios F, Ruiz P, Chen L, Saghesima J, Ciancio G, Burke GW, Goldstein M, Chandar J, Contreras G, Roth D, Kupin W, Guerra G, Vianna R.
    Clin Transpl; 2014 Oct; ():171-8. PubMed ID: 26281142
    [Abstract] [Full Text] [Related]

  • 12. Clinical Relevance of Posttransplant DSAs in Patients Receiving Desensitization for HLA-incompatible Kidney Transplantation.
    Vo AA, Aubert O, Haas M, Huang E, Zhang X, Choi J, Peng A, Najjar R, Sethi S, Ammerman N, Lim K, Jordan SC.
    Transplantation; 2019 Dec; 103(12):2666-2674. PubMed ID: 30883456
    [Abstract] [Full Text] [Related]

  • 13. Long-term results of desensitization protocol with and without rituximab in sensitized kidney transplant recipients.
    Green H, Nesher E, Aizner S, Israeli M, Klein T, Zakai H, Rahamimov R, Rozen-Zvi B, Mor E.
    Clin Transplant; 2019 Jun; 33(6):e13562. PubMed ID: 30941818
    [Abstract] [Full Text] [Related]

  • 14. Antibody depletion strategy for the treatment of suspected antibody-mediated rejection in lung transplant recipients: Does it work?
    Vacha M, Chery G, Hulbert A, Byrns J, Benedetti C, Finlen Copeland CA, Gray A, Onwuemene O, Palmer SM, Snyder LD.
    Clin Transplant; 2017 Mar; 31(3):. PubMed ID: 27988971
    [Abstract] [Full Text] [Related]

  • 15. Preformed C1q-binding Donor-specific Anti-HLA Antibodies and Graft Function After Kidney Transplantation.
    Okabe Y, Noguchi H, Miyamoto K, Kaku K, Tsuchimoto A, Masutani K, Nakamura M.
    Transplant Proc; 2018 Dec; 50(10):3460-3466. PubMed ID: 30577221
    [Abstract] [Full Text] [Related]

  • 16. Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation.
    Caro-Oleas JL, González-Escribano MF, González-Roncero FM, Acevedo-Calado MJ, Cabello-Chaves V, Gentil-Govantes MÁ, Núñez-Roldán A.
    Nephrol Dial Transplant; 2012 Mar; 27(3):1231-8. PubMed ID: 21810767
    [Abstract] [Full Text] [Related]

  • 17. Deceased donor kidney transplantation across donor-specific antibody barriers: predictors of antibody-mediated rejection.
    Schwaiger E, Eskandary F, Kozakowski N, Bond G, Kikić Ž, Yoo D, Rasoul-Rockenschaub S, Oberbauer R, Böhmig GA.
    Nephrol Dial Transplant; 2016 Aug; 31(8):1342-51. PubMed ID: 27190362
    [Abstract] [Full Text] [Related]

  • 18. Characteristics of donor-specific anti-HLA antibodies and outcome in renal transplant patients treated with a standardized induction regimen.
    Zecher D, Bach C, Staudner C, Böger CA, Bergler T, Banas B, Spriewald BM.
    Nephrol Dial Transplant; 2017 Apr 01; 32(4):730-737. PubMed ID: 28339671
    [Abstract] [Full Text] [Related]

  • 19. Impact of pre-transplant donor specific antibodies detected by Luminex with negative microlymphocytotoxicity assay and flow crossmatch in live-related renal transplant recipients.
    Abbas K, Aziz T, Musharaf W, Mubarak M, Zafar MN.
    Clin Transplant; 2023 May 01; 37(5):e14935. PubMed ID: 36799009
    [Abstract] [Full Text] [Related]

  • 20. Donor-specific antibody characteristics, including persistence and complement-binding capacity, increase risk for chronic lung allograft dysfunction.
    Iasella CJ, Ensor CR, Marrari M, Mangiola M, Xu Q, Nolley E, Moore CA, Morrell MR, Pilewski JM, Sanchez PG, McDyer JF, Zeevi A.
    J Heart Lung Transplant; 2020 Dec 01; 39(12):1417-1425. PubMed ID: 32981841
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.